Dr John Buscombe

British Nuclear Medicine Society

Dr John Buscombe is the President of the British Nuclear Medicine Society and works as a Consultant Physician in Nuclear Medicine in Cambridge.

dont miss

Theranostics in prostate cancer new or false dawn

Over the past 2 years new imaging and therapeutic options using radiolabelled prostate specific membrane antigen have been developed which enable us to see disease which cannot be found by other methods with gallium-68 PSMA PET-CT. Newer work has linked this to targeted radionuclide therapy using beta and alpha emitter labelled PSMA is previously untreatable metastatic prostate cancer which is being actively developed.

EVEN MORE SEMINARS

  • Dr Jagrit Shah: Speaking at the European Neurological Convention

    Dr Jagrit Shah
    Vice President of the British Society of Head & Neck Imaging

    Chairing Session 3. Upper Aerodigestive Tract

  • Dr Sam Hare: Speaking at the European Neurological Convention

    Dr Sam Hare
    Royal Free London NHS Foundation Trust

    How I evaluate lung lesions for CT-guided biopsy?

  • Dr Youssef Mentias: Speaking at the European Neurological Convention

    Dr Youssef Mentias
    CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST

    Ultrasound Thyroid Nodule Evaluation

  • Prof. Iris Grunwald: Speaking at the European Neurological Convention

    Prof. Iris Grunwald
    Anglia Ruskin University, School of Medicine; Southend University Hospital

    Pioneering treatment mechanical thrombectomy

  • Estevao Mauricio Bagi: Speaking at the European Neurological Convention

    Estevao Mauricio Bagi
    Royal Brompton & Harefield Hospitals Specialist Care

    Cardiac PET-CT : Rubidium-82 Myocardium Perfusion & 18F-FDG Cardiac Sarcoidosis